It was just a few years ago that many doubted that large-scale antiretroviral treatment programs could work in the world's poorest nations. Now we know such programs can work. Hundreds of thousands of people are proving it.
As of March 31, 2008, approximately 1.73 million people -- including nearly 1.64 million in the 15 focus countries -- received treatment with support from rapidly scaled-up bilateral PEPFAR partnerships with host nations.
In FY2007, PEPFAR provided $1.34 billion in support of treatment programs, including treatment for pediatric patients, or 48 percent of program funding in the focus countries.
Five-Year Goal in the 15 Focus Countries:
Progress Achieved through March 31, 2008:
- Support antiretroviral treatment (ART) for two million HIV-infected individuals
-- The Power of Partnerships: Fourth Annual Report to Congress on PEPFAR - Partnerships for Treatment (2008)
- Globally, PEPFAR supported life-saving antiretroviral treatment for approximately 1.73 million men, women and children.
- Of this, PEPFAR supported life-saving antiretroviral treatment for more than 1.64 million people through bilateral programs in PEPFAR's 15 focus countries in sub-Saharan Africa, Asia and the Caribbean.
- When President Bush announced PEPFAR, it was estimated that only 50,000 people were receiving treatment for HIV/AIDS in sub-Saharan Africa. Of those for whom PEPFAR supported treatment as of March 2008, nearly 1.68 million are in this region.
||Fact Sheets and Issue Briefs|| |